PSTV vs RTX · P/E 0.2, rev $5.8M vs P/E 36, rev $46.78B
Plus Therapeutics Inc (PSTV) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Latest reported RTX revenue for 2026-06-30 was $46.78B. Net income was $4.20B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
PSTV currently screens at market cap $29.7M and trailing P/E 0.2. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the PSTV and RTX stock pages for the full models.
Not investment advice.